spacer
spacer
Go to PDB code: 
protein links
Signaling protein PDB id
2pz1
Jmol
Contents
Protein chain
408 a.a. *
Waters ×100
* Residue conservation analysis
PDB id:
2pz1
Name: Signaling protein
Title: Crystal structure of auto-inhibited asef
Structure: Rho guanine nucleotide exchange factor 4. Chain: a. Synonym: apc-stimulated guanine nucleotide exchange factor, engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: arhgef4, kiaa1112. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.25Å     R-factor:   0.221     R-free:   0.279
Authors: L.Betts,J.Sondek,K.L.Rossman
Key ref:
N.Mitin et al. (2007). Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression. Nat Struct Biol, 14, 814-823. PubMed id: 17704816 DOI: 10.1038/nsmb1290
Date:
17-May-07     Release date:   21-Aug-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q9NR80  (ARHG4_HUMAN) -  Rho guanine nucleotide exchange factor 4
Seq:
Struc:
 
Seq:
Struc:
690 a.a.
408 a.a.
Key:    PfamA domain  PfamB domain  Secondary structure

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     intracellular   1 term 
  Biological process     intracellular signal transduction   2 terms 
  Biochemical function     protein binding     3 terms  

 

 
DOI no: 10.1038/nsmb1290 Nat Struct Biol 14:814-823 (2007)
PubMed id: 17704816  
 
 
Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression.
N.Mitin, L.Betts, M.E.Yohe, C.J.Der, J.Sondek, K.L.Rossman.
 
  ABSTRACT  
 
Autoinhibition of the Rho guanine nucleotide exchange factor ASEF is relieved by interaction with the APC tumor suppressor. Here we show that binding of the armadillo repeats of APC to a 'core APC-binding' (CAB) motif within ASEF, or truncation of the SH3 domain of ASEF, relieves autoinhibition, allowing the specific activation of CDC42. Structural determination of autoinhibited ASEF reveals that the SH3 domain forms an extensive interface with the catalytic DH and PH domains to obstruct binding and activation of CDC42, and the CAB motif is positioned adjacent to the SH3 domain to facilitate activation by APC. In colorectal cancer cell lines, full-length, but not truncated, APC activates CDC42 in an ASEF-dependent manner to suppress anchorage-independent growth. We therefore propose a model in which ASEF acts as a tumor suppressor when activated by APC and inactivation of ASEF by mutation or APC truncation promotes tumorigenesis.
 
  Selected figure(s)  
 
Figure 5.
(a) Schematic representations of full-length and truncated human APC. Top, APC contains oligomerization domain (OD), armadillo-repeat domain (ARM), regions for -catenin binding (15-residue repeats) and downregulation (20-residue repeats), sequences for Axin binding (SAMP repeats), basic domain that interacts directly with microtubules (MT), and EB1-binding region for indirect association with MTs. Bottom, APC is often mutated within the mutational cluster region (MCR) in cancers, leading to truncated protein. APC 1061 is a truncated form of APC that results from a common germline mutation. (b) Activated ASEF and CDC42 induce similar ruffles in COS-7 cells.
Figure 6.
(a) Ribbon diagram of ASEF. The SH3 domain forms an extensive interface with the DH and PH domains. The core APC-binding motif within the ABR contains a small -helix ( CAB) that rests against the n-Src loop of the SH3 domain. Dashed line represents disordered linker region between the SH3 and DH domains. (b) Comparison of autoinhibited ASEF with collybistin bound to CDC42. The structure of the collybistin DH and PH domains bound to CDC42 (PDB 2DFK) was superimposed on the structure of ASEF by aligning their DH domains. In this conformation, the DH and PH domains of ASEF could not bind CDC42 owing to steric clash, and large conformational differences are evident between the inhibited (ASEF) and activated (collybistin) states. Dashed lines indicate sites of steric clash; S2 is switch 2 in CDC42.
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: Nat Struct Biol (2007, 14, 814-823) copyright 2007.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21311754 T.Sudhaharan, W.I.Goh, K.P.Sem, K.B.Lim, W.Bu, and S.Ahmed (2011).
Rho GTPase Cdc42 is a direct interacting partner of Adenomatous Polyposis Coli protein and can alter its cellular localization.
  PLoS One, 6, e16603.  
  20653955 A.Singh, J.L.Boyer, C.J.Der, and I.E.Zohn (2010).
Transformation by a nucleotide-activated P2Y receptor is mediated by activation of Galphai, Galphaq and Rho-dependent signaling pathways.
  J Mol Signal, 5, 11.  
20842712 C.Kintscher, S.Wuertenberger, R.Eylenstein, T.Uhlendorf, and Y.Groemping (2010).
Autoinhibition of GEF activity in Intersectin 1 is mediated by the short SH3-DH domain linker.
  Protein Sci, 19, 2164-2174.  
21102635 D.Vigil, J.Cherfils, K.L.Rossman, and C.J.Der (2010).
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
  Nat Rev Cancer, 10, 842-857.  
19901077 K.H.Lim, D.C.Brady, D.F.Kashatus, B.B.Ancrile, C.J.Der, A.D.Cox, and C.M.Counter (2010).
Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.
  Mol Cell Biol, 30, 508-523.  
20345913 S.Reddy-Alla, B.Schmitt, J.Birkenfeld, V.Eulenburg, S.Dutertre, C.Böhringer, M.Götz, H.Betz, and T.Papadopoulos (2010).
PH-domain-driven targeting of collybistin but not Cdc42 activation is required for synaptic gephyrin clustering.
  Eur J Neurosci, 31, 1173-1184.  
19897489 Y.Kawasaki, T.Jigami, S.Furukawa, M.Sagara, K.Echizen, Y.Shibata, R.Sato, and T.Akiyama (2010).
The adenomatous polyposis coli-associated guanine nucleotide exchange factor Asef is involved in angiogenesis.
  J Biol Chem, 285, 1199-1207.  
19151759 M.Sagara, Y.Kawasaki, S.I.Iemura, T.Natsume, Y.Takai, and T.Akiyama (2009).
Asef2 and Neurabin2 cooperatively regulate actin cytoskeletal organization and are involved in HGF-induced cell migration.
  Oncogene, 28, 1357-1365.  
19460155 M.Zheng, T.Cierpicki, K.Momotani, M.V.Artamonov, U.Derewenda, J.H.Bushweller, A.V.Somlyo, and Z.S.Derewenda (2009).
On the mechanism of autoinhibition of the RhoA-specific nucleotide exchange factor PDZRhoGEF.
  BMC Struct Biol, 9, 36.  
19737524 S.Guerrier, J.Coutinho-Budd, T.Sassa, A.Gresset, N.V.Jordan, K.Chen, W.L.Jin, A.Frost, and F.Polleux (2009).
The F-BAR domain of srGAP2 induces membrane protrusions required for neuronal migration and morphogenesis.
  Cell, 138, 990.  
19525225 Y.Kawasaki, S.Tsuji, M.Sagara, K.Echizen, Y.Shibata, and T.Akiyama (2009).
Adenomatous polyposis coli and Asef function downstream of hepatocyte growth factor and phosphatidylinositol 3-kinase.
  J Biol Chem, 284, 22436-22443.  
19845967 Y.Wang, Y.Azuma, D.B.Friedman, R.J.Coffey, and K.L.Neufeld (2009).
Novel association of APC with intermediate filaments identified using a new versatile APC antibody.
  BMC Cell Biol, 10, 75.  
18537266 M.E.Yohe, K.Rossman, and J.Sondek (2008).
Role of the C-terminal SH3 domain and N-terminal tyrosine phosphorylation in regulation of Tim and related Dbl-family proteins.
  Biochemistry, 47, 6827-6839.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.